JP2009521512A5 - - Google Patents

Download PDF

Info

Publication number
JP2009521512A5
JP2009521512A5 JP2008547791A JP2008547791A JP2009521512A5 JP 2009521512 A5 JP2009521512 A5 JP 2009521512A5 JP 2008547791 A JP2008547791 A JP 2008547791A JP 2008547791 A JP2008547791 A JP 2008547791A JP 2009521512 A5 JP2009521512 A5 JP 2009521512A5
Authority
JP
Japan
Prior art keywords
composition
targeting peptide
subject
endometriosis
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2008547791A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009521512A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/062601 external-priority patent/WO2007076501A2/en
Publication of JP2009521512A publication Critical patent/JP2009521512A/ja
Publication of JP2009521512A5 publication Critical patent/JP2009521512A5/ja
Ceased legal-status Critical Current

Links

JP2008547791A 2005-12-23 2006-12-26 子宮内膜症細胞ターゲティングペプチドおよびその使用 Ceased JP2009521512A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75367705P 2005-12-23 2005-12-23
PCT/US2006/062601 WO2007076501A2 (en) 2005-12-23 2006-12-26 Endometriosis cell targeting peptide and uses thereof

Publications (2)

Publication Number Publication Date
JP2009521512A JP2009521512A (ja) 2009-06-04
JP2009521512A5 true JP2009521512A5 (enExample) 2010-02-04

Family

ID=38218861

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008547791A Ceased JP2009521512A (ja) 2005-12-23 2006-12-26 子宮内膜症細胞ターゲティングペプチドおよびその使用

Country Status (5)

Country Link
US (2) US9006404B2 (enExample)
EP (1) EP1966234A2 (enExample)
JP (1) JP2009521512A (enExample)
CA (1) CA2634934A1 (enExample)
WO (1) WO2007076501A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7081446B2 (en) * 2002-01-31 2006-07-25 The Trustees Of Columbia University In The City Of New York Long-acting follicle stimulating hormone analogues and uses thereof
US20080306034A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Method of Administering a Therapeutic
US20080305967A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Genetic Markers Associated with Endometriosis and Use Thereof
US8932993B1 (en) 2007-06-11 2015-01-13 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
US20120225824A1 (en) * 2008-08-05 2012-09-06 The Trustees Of Columbia University In The City Of New York Mullerian inhibiting substance (mis) analogues
WO2010124101A2 (en) * 2009-04-22 2010-10-28 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof
US9434991B2 (en) 2013-03-07 2016-09-06 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
US9783576B2 (en) 2013-06-11 2017-10-10 Sanford-Burnham Medical Research Institute Compositions and methods for targeted endometriosis treatment
US11386065B2 (en) * 2017-01-31 2022-07-12 Salesforce.Com, Inc. Database concurrency control through hash-bucket latching
JP6613499B2 (ja) 2017-08-24 2019-12-04 学校法人藤田学園 細胞殺傷剤
AU2020212604A1 (en) * 2019-01-25 2021-07-22 Fertility Lab Sciences, Llc Uterine endometrial fluid for prediction of success in fertility treatment
GB202202919D0 (en) 2022-03-02 2022-04-13 Serac Healthcare Ltd Methods for imaging integrin expression

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660981A (en) * 1994-06-06 1997-08-26 E. I. Du Pont De Nemours And Company Selection of diagnostic genetic markers in microorganisms and use of a specific marker for detection of salmonella
WO2000059547A2 (en) * 1999-04-02 2000-10-12 Center For Molecular Medicine And Immunology Method of detecting endometriosis
WO2000067771A1 (en) * 1999-05-06 2000-11-16 The Burnham Institute Antiangiogenic endostatin peptides, endostatin variants and methods of use
US20040031072A1 (en) * 1999-05-06 2004-02-12 La Rosa Thomas J. Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
AU2001277840A1 (en) * 2000-03-07 2002-03-04 Hyseq, Inc. Novel nucleic acids and polypeptides
AU5108201A (en) * 2000-03-30 2001-10-15 Amgen Inc Cd20/ige-receptor like molecules and uses thereof
US20040001823A1 (en) * 2000-04-19 2004-01-01 Yeaman Grant R. Methods of treating endometriosis
US6833447B1 (en) * 2000-07-10 2004-12-21 Monsanto Technology, Llc Myxococcus xanthus genome sequences and uses thereof
US7214786B2 (en) * 2000-12-14 2007-05-08 Kovalic David K Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
US7314974B2 (en) * 2002-02-21 2008-01-01 Monsanto Technology, Llc Expression of microbial proteins in plants for production of plants with improved properties

Similar Documents

Publication Publication Date Title
ES2642628T3 (es) Suministro oral mejorado de péptidos, mediante la utilización de translocadores de membrana, segmentables mediante una enzima
JP2009521512A5 (enExample)
CN101553243B (zh) 组织损伤修复中的基质细胞衍生因子1的蛋白酶抗性突变体
CN104023784B (zh) 供持续释放的活性剂制剂
ES2773766T3 (es) Inhibidores de TFPI y métodos de uso
US20120028880A1 (en) Vegfr-1/nrp-1 targeting peptides
JP2017513859A (ja) 両末端peg化インテグリン結合性ペプチドおよびその使用方法
JP2008536483A5 (enExample)
RU2012106150A (ru) Вариантные формы уратоксидазы и их применение
JP2007508846A5 (enExample)
TW201629085A (zh) 芋螺毒素(conotoxin)肽之修飾及用途
US20140073555A1 (en) Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation
US20140322332A1 (en) Antagonists of muc1
US10206976B2 (en) Protein particles comprising disulfide crosslinkers and uses related thereto
McGonigle et al. Neuropilin-1 drives tumor-specific uptake of chlorotoxin
US20160207969A1 (en) Clostridium difficile targeting moieties and constructs comprising said moieties
CN110256574B (zh) 融合多肽及在制备抗抑郁、神经退行性疾病药物中的应用
WO2018136779A2 (en) OXALOBACTER FORMIGENES(Of)-DERIVED FACTORS FOR THE TREATMENT OF TREATMENT/PREVENTION OF EXCESS OXALATE LEVELS
JP2012524079A5 (enExample)
CN115243699A (zh) 分子导向系统肽及其用途
CN101906152B (zh) STX2抑制性肽以及Vero毒素中和剂
CN107949372A (zh) 烯醇酶1(Eno1)组合物及其用途
BRPI0906045B1 (pt) Composição farmacêutica para administração nasal
EP1602931A1 (en) SR-A antagonists
US12016899B2 (en) Compositions comprising Sel1-derived peptides and methods of treatment/prevention of excess oxalate levels and associated conditions/diseases therewith